Name

M3 India

Legal name

Neuroglia Health Private Limited

Website

https://corporate.m3india.in

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Healthcare Marketing & Physician Engagement

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Healthcare marketing services
• Doctor engagement platform
• Pharmaceutical marketing solutions
• Medical market research
• Continuing medical education

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Marketing Campaigns: Plan and execute content marketing campaigns targeting doctors based on customer profiles and therapy areas. Healthcare brands can engage the doctor community with targeted promotional campaigns.
2. Market Research & Consulting: Online market research solutions to generate quick actionable insights or conduct detailed market assessments. Includes quantitative and qualitative research capabilities.
3. Education (eCME Programs): Application-based eCME programs delivered in partnership with leading Medical Associations, helping pharmaceutical companies support medical education initiatives at scale.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

M3 India operates a proprietary B2B healthcare engagement platform that connects pharmaceutical and healthcare brands with a verified community of 150,000+ Indian doctors across 50+ medical specialties. The company delivers three core offerings: targeted marketing campaigns via multi-channel outreach (in-app alerts, SMS, email, social media), online market research and consulting (qualitative and quantitative studies), and application-based electronic Continuing Medical Education (eCME) programs in partnership with leading medical associations.

Product overview

M3 India operates as a multi-module healthcare engagement platform offering three core product lines—Marketing Campaigns, Market Research & Consulting, and Education (eCME Programs)—built around a proprietary community of 150,000+ verified Indian doctors across 50+ medical specialties. The platform provides healthcare brands with targeted marketing reach, online market research capabilities, and medical education program delivery. All products are accessible through the main M3 India Platform at www.m3india.in, with corporate information at corporate.m3india.in. The parent entity Neuroglia Health Private Limited (NHPL) also owns the Marrow mobile app for medical exam preparation.

Differentiator

Problem solved

Functional benefit

Brands

• Marrow: Leading test preparation platform for NEET PG exams for doctors, owned by Neuroglia Health Private Limited.

Products and services

• Marketing Campaigns Promotional marketing solution enabling healthcare brands to plan and execute content marketing campaigns targeting doctors through pre-recorded videos, live webinars, and panel discussions using multi-channel outreach including in-app alerts, SMS, emails, and social media. Targeted at healthcare marketers and pharmaceutical companies.
• Market Research & Consulting Online market research solution offering qualitative and quantitative studies including pricing studies, market assessment, and communication testing, with a panel of verified doctors across metros and smaller cities and turnaround times 60-70% lower than offline research. Targeted at pharmaceutical and healthcare research clients.
• Education (eCME Programs) Application-based electronic Continuing Medical Education (eCME) programs delivered in partnership with leading medical associations and certified by bodies such as RSSDI, featuring video modules, assessments, and certificates of completion for doctors. Helps pharmaceutical companies support medical education initiatives at scale.
• Marrow Mobile App Leading test preparation mobile application for NEET PG medical exams, owned by Neuroglia Health Private Limited (NHPL), the consolidated entity of M3 India's Indian operations. Targeted at medical students and doctors preparing for postgraduate entrance exams.

Quantifiable outcome

• 60-70% lower turnaround time vs offline research
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• RSSDI (Research Society for the Study of Diabetes in India)coreStrategic or Co-development PartnerRSSDI is a leading medical association that partnered with M3 India for eCME certification. The 'Diabetology in Primary Care' eCME was certified by RSSDI, and doctors who completed the program received certificates of completion from RSSDI.
• M3 GroupcoreStrategic or Co-development PartnerM3 India is part of the M3 Group, a Tokyo-headquartered MNC with operations across 9 countries and 6mn+ doctors globally. The parent company has global sales exceeding USD 1.5 billion and provides the brand, technology platform, and operational framework for Indian operations.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Sermo: Sermo runs a global verified-physician community used for market research, insights, and pharma-sponsored engagement. It is comparable to M3 India's market research and survey monetization layer for healthcare brand clients across multiple geographies.
• Medvarsity: Medvarsity is an India-focused online medical education and certification provider offering courses and CME-style content to doctors. It overlaps with M3 India's eCME programs and certification-based education business, especially in non-metro Indian markets.
• Figure 1: Figure 1 operates a verified-physician community for clinical case sharing and medical education, comparable in concept (verified doctor network + educational content monetized with pharma) to M3 India's eCME and engagement modules.

Broad incumbents

• Veeva Systems: Veeva provides CRM, data, and commercial software to global life sciences companies, including physician engagement and medical content workflows. While not a direct competitor on the India panel, its technology stack defines how pharma clients expect physician engagement platforms to integrate.
• Doximity: Doximity is the largest verified-physician professional network in the US, monetizing access to doctors via pharma marketing, market research, and recruiting. It is a useful analogue for M3 India's business model of running a doctor platform with pharma as the primary paying customer.
• Indegene: Indegene is a larger India-headquartered healthcare commercialization services provider offering medical affairs, marketing, and digital engagement solutions to global pharma. It competes with M3 India in pharma digital marketing and content/CME delivery, but operates a much broader services portfolio beyond physician engagement.
• IQVIA: IQVIA is a global healthcare data, analytics, and commercial services provider that monetizes access to physician panels and delivers market research and sales/marketing solutions to pharma — overlapping with M3 India's research and pharma-marketing offerings at a much larger scale.

Others

• CureMetrix: Adjacent health-IT provider rather than a direct competitor; included only as an example of the broader Indian health-tech ecosystem where B2B services to healthcare brands operate.

Direct peers

• Doceree: Doceree operates a physician-only digital marketing and programmatic ad platform, overlapping directly with M3 India's core offering of pharma-to-doctor targeted campaigns, market research, and eCME. Both monetize access to large verified doctor audiences for healthcare brand clients.
• Prepladder: Prepladder is one of the leading India-based NEET PG and medical entrance exam preparation platforms, directly competing with M3 India's Marrow sub-brand in the same exam-prep category and overlapping doctor user base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/m3-india

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M3 India